New Delhi: Serum Institute of India (SII) today clarified that all claims surrounding the availability of its COVID-19 vaccine, COVISHIELD in 73 days are false.
In a statement, SII said that the current claims surrounding COVISHIELD’s availability in the media are completely false and conjectural.
“Presently, the government has granted us permission to only manufacture the vaccine and stockpile it for future use. COVISHIELD will be commercialised once the trials are proven successful and all the requisite regulatory approvals are in place”, the statement reads.
The phase-3 trials for the Oxford-AstraZeneca vaccine, are still underway. And only once the vaccine is proven immunogenic and efficacious, SII will confirm its availability, officially, it added.